Drug intelligence / Profile preview

Yizhi Decoction

Development stage: Preclinical
Lead developer: Wuhan University of Science and Technology
Administration: Oral

Overview

Yizhi Decoction (also known as Yizhi Tang) is a Traditional Chinese Medicine (TCM) herbal formulation being evaluated for its therapeutic potential in Alzheimer's disease. In a clinical trial sponsored by Wuhan University of Science and Technology (ChiCTR2100049771), the decoction is being studied for its ability to improve clinical symptoms and address abnormal pathological changes in patients with Alzheimer's. As a decoction, it is prepared by boiling a combination of medicinal herbs, a common practice in TCM aimed at synergistic multi-target effects, which may include neuroprotection and cognitive enhancement.

Other names: Yizhi Tang益智汤

Beyond the preview

Go deeper on Yizhi Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yizhi Decoction.

Explore the full profile